India's innovation adoption makes it a strong long-term market: Aker BioMarine CEO

IANS | June 24, 2026 10:48 AM

Dalian (China), June 24 (IANS) Rapid adoption of innovation and technology, coupled with a growing middle class and a large consumer base, will continue to make India a strong long-term market, Norwegian biotechnology firm Aker BioMarine's Chief Executive Officer (CEO) Matts Johansen said on Wednesday at the World Economic Forum's Annual Meeting of the New Champions, also known as the Summer Davos.

S. Korea calls for aggressive investment in AI infrastructure

IANS | June 24, 2026 9:14 AM

Seoul, June 24 (IANS) The presidential policy chief said on Wednesday that the advent of a new artificial intelligence (AI) era requires new state infrastructure, calling for aggressive investment to bolster the country's potential growth trajectory in AI.

Trump administration backs USD 17.5 billion plan for nuclear revival

IANS | June 23, 2026 9:11 PM

Washington, June 23 (IANS) The Donald Trump administration on Tuesday unveiled a USD 17.5 billion financing programme aimed at rebuilding the US nuclear supply chain and accelerating construction of 10 new large-scale nuclear reactors, marking one of the most ambitious efforts in decades to revive America's commercial nuclear industry.

VOC Port becomes a model for green maritime growth: Sarbananda Sonowal

IANS | June 23, 2026 6:11 PM

New Delhi, June 23 (IANS) The VO Chidambaranar Port Authority (VOCPA) has emerged as a model for sustainable maritime development in India, citing the port's significant progress in decarbonisation, renewable energy adoption and green infrastructure development, Union Minister of Ports, Shipping and Waterways (MoPSW), Sarbananda Sonowal, said on Tuesday.

India needs quantum jump into manufacturing high-value pharma products: Economists

IANS | June 23, 2026 6:06 PM

New Delhi, June 23 (IANS) India, which is one of the world’s largest suppliers of generic medicines and a major provider of vaccines and essential drugs, needs to make a quantum jump into manufacturing high-value pharmaceuticals and Active Pharmaceutical Ingredients (API), and there has to be strong Production Linked Incentive (PLI) schemes to achieve this, economists said on Tuesday.